Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Nifedipine | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Nifedipine | hsa00061 | Fatty acid biosynthesis | 4.83E-02 | 1 | P33121 | ACSL1 | More | | Nifedipine | hsa00190 | Oxidative phosphorylation | 3.50E-02 | 2 | Q16718, Q13488 | NDUFA5, TCIRG1 | More | | Nifedipine | hsa00230 | Purine metabolism | 4.60E-02 | 4 | Q13370, P36959, Q13956, P27707 | PDE3B, GMPR, PDE6H, DCK | More | | Nifedipine | hsa00240 | Pyrimidine metabolism | 4.50E-02 | 2 | P32320, P27707 | CDA, DCK | More | | Nifedipine | hsa00500 | Starch and sucrose metabolism | 1.67E-02 | 2 | O43451, P06737 | MGAM, PYGL | More | | Nifedipine | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 3.43E-02 | 1 | Q9NY97 | B3GNT2 | More | | Nifedipine | hsa00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 4.77E-02 | 1 | Q7LGA3 | HS2ST1 | More | | Nifedipine | hsa00600 | Sphingolipid metabolism | 3.01E-02 | 2 | Q9BX95, P06280 | SGPP1, GLA | More | | Nifedipine | hsa00604 | Glycosphingolipid biosynthesis - ganglio series | 1.34E-02 | 2 | P06865, Q9H4F1 | HEXA, ST6GALNAC4 | More | | Nifedipine | hsa00620 | Pyruvate metabolism | 4.20E-02 | 2 | P40926, P14550 | MDH2, AKR1A1 | More | | Nifedipine | hsa00670 | One carbon pool by folate | 3.99E-02 | 2 | O95954, Q99707 | FTCD, MTR | More | | Nifedipine | hsa00730 | Thiamine metabolism | 5.29E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Nifedipine | hsa00920 | Sulfur metabolism | 3.01E-02 | 1 | O95571 | ETHE1 | More | | Nifedipine | hsa00983 | Drug metabolism - other enzymes | 2.44E-02 | 2 | P32320, P05164 | CDA, MPO | More | | Nifedipine | hsa01100 | Metabolic pathways | 6.77E-03 | 32 | Q9Y234, P15144, Q99707, P29218, P11310, P27707, P32320, Q13370, P36959, Q13956, P06280, P30043, P24666, Q02252, O60701, O14772, O95954, P33121, Q02318, P42330, P04406, Q13093, Q9NY28, O15466, Q9BX95, P09960, Q9P2R7, Q9UHY7, P35573, Q13488, Q16718, Q02809 | LIPT1, ANPEP, MTR, IMPA1, ACADM, DCK, CDA, PDE3B, GMPR, PDE6H, GLA, BLVRB, ACP1, ALDH6A1, UGDH, FPGT, FTCD, ACSL1, CYP27A1, AKR1C3, GAPDH, PLA2G7, GALNT8, ST8SIA5, SGPP1, LTA4H, SUCLA2, ENOPH1, AGL, TCIRG1, NDUFA5, PLOD1 | More | | Nifedipine | hsa01524 | Platinum drug resistance | 4.45E-02 | 4 | P10415, Q13489, P78417, P43246 | BCL2, BIRC3, GSTO1, MSH2 | More | | Nifedipine | hsa02010 | ABC transporters | 4.89E-02 | 1 | Q99758 | ABCA3 | More | | Nifedipine | hsa03010 | Ribosome | 3.56E-06 | 14 | P62753, P42677, P32969, P40429, P62917, P46776, Q9H0U6, Q07020, P62910, Q02878, P36578, P05386, P62249, P23396 | RPS6, RPS27, RPL9, RPL13A, RPL8, RPL27A, MRPL18, RPL18, RPL32, RPL6, RPL4, RPLP1, RPS16, RPS3 | More | | Nifedipine | hsa03013 | RNA transport | 4.79E-02 | 2 | P62826, P63279 | RAN, UBE2I | More | | Nifedipine | hsa03015 | mRNA surveillance pathway | 3.62E-02 | 3 | O43148, P61326, P52298 | RNMT, MAGOH, NCBP2 | More | | Nifedipine | hsa03020 | RNA polymerase | 9.86E-07 | 2 | Q9GZM3, P52435 | POLR2J2, POLR2J | More | | Nifedipine | hsa03040 | Spliceosome | 1.11E-07 | 18 | Q14562, O43143, O60508, P17844, O14776, P08579, O75940, P52298, P09651, Q15365, O75494, Q07955, Q01130, Q13243, P11142, O95777, O43447, P61326 | DHX8, DHX15, CDC40, DDX5, TCERG1, SNRPB2, SMNDC1, NCBP2, HNRNPA1, PCBP1, FUSIP1, SFRS1, SFRS2, SFRS5, HSPA8, LSM8, PPIH, MAGOH | More | | Nifedipine | hsa03050 | Proteasome | 5.53E-03 | 2 | P43686, P28070 | PSMC4, PSMB4 | More | | Nifedipine | hsa03320 | PPAR signaling pathway | 2.18E-02 | 2 | O00767, Q02318 | SCD, CYP27A1 | More | | Nifedipine | hsa03460 | Fanconi anemia pathway | 3.70E-03 | 3 | Q9NPI8, O60673, Q9UNA4 | FANCF, REV3L, POLI | More | | Nifedipine | hsa04014 | Ras signaling pathway | 2.65E-03 | 9 | P31751, P20827, P49767, Q13009, P17252, Q15311, P0DP23, P62873, P19174 | AKT2, EFNA1, VEGFC, TIAM1, PRKCA, RALBP1, CALM1, GNB1, PLCG1 | More | | Nifedipine | hsa04015 | Rap1 signaling pathway | 5.41E-03 | 9 | P20827, P49767, Q13009, Q08828, P51828, P31751, P0DP23, P17252, P19174 | EFNA1, VEGFC, TIAM1, ADCY1, ADCY7, AKT2, CALM1, PRKCA, PLCG1 | More | | Nifedipine | hsa04020 | Calcium signaling pathway | 1.04E-06 | 11 | P27987, Q08828, Q13557, P17252, O15399, P19174, P61073, P0DP23, P51828, P23634, P49767 | ITPKB, ADCY1, CAMK2D, PRKCA, GRIN2D, PLCG1, CXCR4, CALM1, ADCY7, ATP2B4, VEGFC | More | | Nifedipine | hsa04024 | cAMP signaling pathway | 2.79E-04 | 13 | P49019, Q08828, P51828, P22694, P31751, P0DP23, P20020, P23634, Q13557, Q13370, P48058, O15399, Q13009 | HCAR3, ADCY1, ADCY7, PRKACB, AKT2, CALM1, ATP2B1, ATP2B4, CAMK2D, PDE3B, GRIA4, GRIN2D, TIAM1 | More | | Nifedipine | hsa04062 | Chemokine signaling pathway | 2.04E-02 | 10 | P51684, Q8NHW4, P19174, P62873, Q08828, P51828, Q13009, P14598, P42224, P31751 | CCR6, CCL4L2, PLCG1, GNB1, ADCY1, ADCY7, TIAM1, NCF1, STAT1, AKT2 | More | | Nifedipine | hsa04064 | NF-kappa B signaling pathway | 1.74E-05 | 12 | P10415, Q13489, P51617, Q13546, P01584, P29965, P19174, Q9UDY8, O75293, Q8NHW4, Q9UNE0, Q9NQC7 | BCL2, BIRC3, IRAK1, RIPK1, IL1B, CD40LG, PLCG1, MALT1, GADD45B, CCL4L2, EDAR, CYLD | More | | Nifedipine | hsa04070 | Phosphatidylinositol signaling system | 5.66E-04 | 6 | P19174, P0DP23, P23743, P48426, P27987, P17252 | PLCG1, CALM1, DGKA, PIP4K2A, ITPKB, PRKCA | More | | Nifedipine | hsa04071 | Sphingolipid signaling pathway | 2.78E-03 | 8 | P17252, Q9H228, P01375, Q13510, Q13362, P10415, Q9UQC2, P01042 | PRKCA, EDG8, TNF, ASAH1, PPP2R5C, BCL2, GAB2, KNG1 | More | | Nifedipine | hsa04072 | Phospholipase D signaling pathway | 2.03E-02 | 8 | P31751, P19174, P17252, Q15438, Q08828, P51828, P23743, P00734 | AKT2, PLCG1, PRKCA, PSCD1, ADCY1, ADCY7, DGKA, F2 | More | | Nifedipine | hsa04140 | Autophagy - animal | 2.58E-02 | 7 | P31751, Q7L523, Q96RR4, O75460, P10415, Q96GC9, Q8TEV9 | AKT2, RRAGA, CAMKK2, ERN1, BCL2, TMEM49, SMCR8 | More | | Nifedipine | hsa04144 | Endocytosis | 8.99E-03 | 12 | P11142, Q9H444, O43633, O75351, Q9NZZ3, Q15438, Q14161, P14784, Q96QK1, Q9UMY4, Q9Y5X3, Q9UNH7 | HSPA8, CHMP4B, CHMP2A, VPS4B, CHMP5, PSCD1, GIT2, IL2RB, VPS35, SNX12, SNX5, SNX6 | More | | Nifedipine | hsa04145 | Phagosome | 4.88E-04 | 9 | P60709, P63261, Q15075, Q15080, P14598, Q13509, P68371, Q13488, O60603 | ACTB, ACTG1, EEA1, NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, TLR2 | More | | Nifedipine | hsa04151 | PI3K-Akt signaling pathway | 4.68E-03 | 18 | O43521, P27348, P20827, P49767, Q13362, P08238, P62873, P16144, P48551, P14784, P23458, P01568, P15336, P18848, P10415, P17252, Q16513, Q6ZUJ8 | BCL2L11, YWHAQ, EFNA1, VEGFC, PPP2R5C, HSP90AB1, GNB1, ITGB4, IFNAR2, IL2RB, JAK1, IFNA21, ATF2, ATF4, BCL2, PRKCA, PKN2, PIK3AP1 | More | | Nifedipine | hsa04210 | Apoptosis | 7.52E-04 | 7 | O76075, P07384, P01375, Q9NR28, Q16548, P60709, P63261 | DFFB, CAPN1, TNF, DIABLO, BCL2A1, ACTB, ACTG1 | More | | Nifedipine | hsa04211 | Longevity regulating pathway | 1.18E-02 | 3 | Q12778, Q9UEF7, Q96KQ7 | FOXO1, KL, EHMT2 | More | | Nifedipine | hsa04215 | Apoptosis - multiple species | 1.56E-02 | 2 | Q13489, P10415 | BIRC3, BCL2 | More | | Nifedipine | hsa04217 | Necroptosis | 2.51E-10 | 17 | P01568, P23458, Q13489, Q9NQC7, Q13546, P42224, P08238, P01584, P0C0S5, Q6FI13, P10415, Q13557, Q9H444, O43633, Q9NZZ3, O75351, Q08752 | IFNA21, JAK1, BIRC3, CYLD, RIPK1, STAT1, HSP90AB1, IL1B, H2AFZ, H2AC18; H2AC19, BCL2, CAMK2D, CHMP4B, CHMP2A, CHMP5, VPS4B, PPID | More | | Nifedipine | hsa04261 | Adrenergic signaling in cardiomyocytes | 4.43E-06 | 11 | P09493, Q08828, P51828, P31751, P18848, Q13362, P0DP23, Q13557, P17252, P10415, P23634 | TPM1, ADCY1, ADCY7, AKT2, ATF4, PPP2R5C, CALM1, CAMK2D, PRKCA, BCL2, ATP2B4 | More | | Nifedipine | hsa04340 | Hedgehog signaling pathway | 3.32E-02 | 2 | P49841, P22694 | GSK3B, PRKACB | More | | Nifedipine | hsa04360 | Axon guidance | 8.44E-04 | 8 | P61073, P16333, P20827, O95631, P17252, Q13557, P23528, P19174 | CXCR4, NCK1, EFNA1, NTN1, PRKCA, CAMK2D, CFL1, PLCG1 | More | | Nifedipine | hsa04371 | Apelin signaling pathway | 3.08E-02 | 7 | P62873, P31751, Q08828, P51828, Q13370, Q13485, P0DP23 | GNB1, AKT2, ADCY1, ADCY7, PDE3B, SMAD4, CALM1 | More | | Nifedipine | hsa04380 | Osteoclast differentiation | 4.18E-02 | 7 | Q9NQC7, Q9UQC2, P23458, P42224, P01584, Q15080, P14598 | CYLD, GAB2, JAK1, STAT1, IL1B, NCF4, NCF1 | More | | Nifedipine | hsa04390 | Hippo signaling pathway | 1.38E-03 | 5 | P60709, P63261, P84022, Q13485, Q13489 | ACTB, ACTG1, SMAD3, SMAD4, BIRC3 | More | | Nifedipine | hsa04510 | Focal adhesion | 3.76E-02 | 7 | P16144, O75369, Q15942, P17252, Q13489, P10415, P49767 | ITGB4, FLNB, ZYX, PRKCA, BIRC3, BCL2, VEGFC | More | | Nifedipine | hsa04520 | Adherens junction | 1.58E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Nifedipine | hsa04530 | Tight junction | 3.88E-03 | 3 | P60709, P63261, P60660 | ACTB, ACTG1, MYL6 | More | | Nifedipine | hsa04540 | Gap junction | 4.08E-02 | 5 | P17252, Q13509, P68371, Q08828, P51828 | PRKCA, TUBB3, TUBB2C, ADCY1, ADCY7 | More | | Nifedipine | hsa04610 | Complement and coagulation cascades | 4.69E-03 | 1 | P0C0L4 | C4A | More | | Nifedipine | hsa04611 | Platelet activation | 2.61E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Nifedipine | hsa04620 | Toll-like receptor signaling pathway | 2.13E-03 | 6 | P51617, Q13546, P01568, P31751, P42224, Q8NHW4 | IRAK1, RIPK1, IFNA21, AKT2, STAT1, CCL4L2 | More | | Nifedipine | hsa04621 | NOD-like receptor signaling pathway | 7.87E-03 | 10 | P01584, P08238, P23458, P42224, P01568, Q9H3M7, Q13489, P43490, P10415, Q13546 | IL1B, HSP90AB1, JAK1, STAT1, IFNA21, TXNIP, BIRC3, PBEF1, BCL2, RIPK1 | More | | Nifedipine | hsa04622 | RIG-I-like receptor signaling pathway | 2.39E-02 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | | Nifedipine | hsa04623 | Cytosolic DNA-sensing pathway | 7.83E-04 | 3 | P01568, Q13546, Q8NHW4 | IFNA21, RIPK1, CCL4L2 | More | | Nifedipine | hsa04630 | JAK-STAT signaling pathway | 1.16E-02 | 8 | P31751, P10415, P42224, P23458, P14784, P16871, Q13651, P01568 | AKT2, BCL2, STAT1, JAK1, IL2RB, IL7R, IL10RA, IFNA21 | More | | Nifedipine | hsa04640 | Hematopoietic cell lineage | 2.82E-03 | 4 | P08514, P21926, P07766, P09564 | ITGA2B, CD9, CD3E, CD7 | More | | Nifedipine | hsa04650 | Natural killer cell mediated cytotoxicity | 2.11E-02 | 4 | P17252, O60880, P26717, P26715 | PRKCA, SH2D1A, KLRC2, KLRC1 | More | | Nifedipine | hsa04657 | IL-17 signaling pathway | 3.31E-02 | 3 | P49841, P14780, P01375 | GSK3B, MMP9, TNF | More | | Nifedipine | hsa04659 | Th17 cell differentiation | 3.17E-02 | 3 | P25963, P84022, Q13485 | NFKBIA, SMAD3, SMAD4 | More | | Nifedipine | hsa04662 | B cell receptor signaling pathway | 3.68E-02 | 2 | P25963, P20023 | NFKBIA, CR2 | More | | Nifedipine | hsa04666 | Fc gamma R-mediated phagocytosis | 2.78E-02 | 6 | P08575, P19174, P23528, Q9UQC2, P14598, P17252 | PTPRC, PLCG1, CFL1, GAB2, NCF1, PRKCA | More | | Nifedipine | hsa04670 | Leukocyte transendothelial migration | 4.07E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Nifedipine | hsa04710 | Circadian rhythm | 1.67E-02 | 2 | Q16526, Q9Y478 | CRY1, PRKAB1 | More | | Nifedipine | hsa04713 | Circadian entrainment | 4.27E-06 | 9 | O15399, P0DP23, Q13557, P17252, P62873, P48058, Q08828, P51828, P22694 | GRIN2D, CALM1, CAMK2D, PRKCA, GNB1, GRIA4, ADCY1, ADCY7, PRKACB | More | | Nifedipine | hsa04714 | Thermogenesis | 2.20E-04 | 7 | P22694, P15336, P60709, P63261, P33121, Q16718, P36542 | PRKACB, ATF2, ACTB, ACTG1, ACSL1, NDUFA5, ATP5C1 | More | | Nifedipine | hsa04720 | Long-term potentiation | 3.26E-03 | 6 | P17252, Q13557, P0DP23, P18848, O15399, Q08828 | PRKCA, CAMK2D, CALM1, ATF4, GRIN2D, ADCY1 | More | | Nifedipine | hsa04721 | Synaptic vesicle cycle | 1.14E-02 | 2 | Q13488, P31645 | TCIRG1, SLC6A4 | More | | Nifedipine | hsa04723 | Retrograde endocannabinoid signaling | 1.20E-03 | 4 | P17252, P48058, P22694, Q16718 | PRKCA, GRIA4, PRKACB, NDUFA5 | More | | Nifedipine | hsa04724 | Glutamatergic synapse | 3.16E-04 | 8 | P48058, O15399, Q08828, P51828, P22694, P17252, P62873, P15104 | GRIA4, GRIN2D, ADCY1, ADCY7, PRKACB, PRKCA, GNB1, GLUL | More | | Nifedipine | hsa04725 | Cholinergic synapse | 4.42E-04 | 8 | Q08828, P51828, P17252, P62873, P18848, Q13557, P31751, P10415 | ADCY1, ADCY7, PRKCA, GNB1, ATF4, CAMK2D, AKT2, BCL2 | More | | Nifedipine | hsa04726 | Serotonergic synapse | 2.62E-02 | 3 | P22694, P17252, P31645 | PRKACB, PRKCA, SLC6A4 | More | | Nifedipine | hsa04727 | GABAergic synapse | 4.08E-02 | 5 | Q08828, P51828, P62873, P46459, P17252 | ADCY1, ADCY7, GNB1, NSF, PRKCA | More | | Nifedipine | hsa04740 | Olfactory transduction | 2.61E-02 | 3 | P62873, Q13557, P0DP23 | GNB1, CAMK2D, CALM1 | More | | Nifedipine | hsa04744 | Phototransduction | 1.30E-05 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Nifedipine | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.32E-05 | 8 | P01584, Q08828, P51828, Q13557, P19174, P17252, P0DP23, P01042 | IL1B, ADCY1, ADCY7, CAMK2D, PLCG1, PRKCA, CALM1, KNG1 | More | | Nifedipine | hsa04910 | Insulin signaling pathway | 2.35E-02 | 3 | P22694, P06737, P49841 | PRKACB, PYGL, GSK3B | More | | Nifedipine | hsa04911 | Insulin secretion | 3.01E-03 | 5 | Q08828, P22694, P17252, P18848, Q13557 | ADCY1, PRKACB, PRKCA, ATF4, CAMK2D | More | | Nifedipine | hsa04912 | GnRH signaling pathway | 2.85E-02 | 5 | P17252, Q08828, P18848, Q13557, P0DP23 | PRKCA, ADCY1, ATF4, CAMK2D, CALM1 | More | | Nifedipine | hsa04913 | Ovarian steroidogenesis | 1.28E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Nifedipine | hsa04914 | Progesterone-mediated oocyte maturation | 3.26E-02 | 6 | Q08828, P51828, P31751, Q13370, Q9UJX4, P08238 | ADCY1, ADCY7, AKT2, PDE3B, ANAPC5, HSP90AB1 | More | | Nifedipine | hsa04915 | Estrogen signaling pathway | 3.28E-03 | 9 | P18848, Q08828, P51828, P31751, P08238, P11142, P0DP23, Q15788, P10415 | ATF4, ADCY1, ADCY7, AKT2, HSP90AB1, HSPA8, CALM1, NCOA1, BCL2 | More | | Nifedipine | hsa04918 | Thyroid hormone synthesis | 3.01E-02 | 2 | P22694, P17252 | PRKACB, PRKCA | More | | Nifedipine | hsa04919 | Thyroid hormone signaling pathway | 5.60E-04 | 6 | P49841, P22694, P60709, P63261, O60244, Q9NVC6 | GSK3B, PRKACB, ACTB, ACTG1, MED14, MED17 | More | | Nifedipine | hsa04920 | Adipocytokine signaling pathway | 4.31E-02 | 2 | Q9Y478, Q96RR4 | PRKAB1, CAMKK2 | More | | Nifedipine | hsa04921 | Oxytocin signaling pathway | 1.77E-03 | 3 | P60660, P60709, P63261 | MYL6, ACTB, ACTG1 | More | | Nifedipine | hsa04923 | Regulation of lipolysis in adipocytes | 2.12E-02 | 4 | Q08828, P51828, Q13370, P31751 | ADCY1, ADCY7, PDE3B, AKT2 | More | | Nifedipine | hsa04925 | Aldosterone synthesis and secretion | 3.12E-05 | 9 | P18848, Q08828, P51828, P0DP23, P17252, Q13557, P22694, P20020, P23634 | ATF4, ADCY1, ADCY7, CALM1, PRKCA, CAMK2D, PRKACB, ATP2B1, ATP2B4 | More | | Nifedipine | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Nifedipine | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.51E-07 | 9 | P84022, Q13485, P01584, P42224, P10415, P31751, P49767, P17252, P19174 | SMAD3, SMAD4, IL1B, STAT1, BCL2, AKT2, VEGFC, PRKCA, PLCG1 | More | | Nifedipine | hsa04935 | Growth hormone synthesis, secretion and action | 3.93E-02 | 6 | P19174, Q08828, P51828, P17252, P31751, P42224 | PLCG1, ADCY1, ADCY7, PRKCA, AKT2, STAT1 | More | | Nifedipine | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 9.85E-05 | 3 | P20020, P17252, P22694 | ATP2B1, PRKCA, PRKACB | More | | Nifedipine | hsa04962 | Vasopressin-regulated water reabsorption | 6.61E-03 | 2 | P22694, Q13561 | PRKACB, DCTN2 | More | | Nifedipine | hsa04970 | Salivary secretion | 5.78E-05 | 7 | Q08828, P51828, P22694, P20020, P23634, P17252, P0DP23 | ADCY1, ADCY7, PRKACB, ATP2B1, ATP2B4, PRKCA, CALM1 | More | | Nifedipine | hsa04971 | Gastric acid secretion | 1.02E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Nifedipine | hsa04972 | Pancreatic secretion | 1.26E-05 | 6 | P20020, P23634, P17252, Q08828, P51828, P62491 | ATP2B1, ATP2B4, PRKCA, ADCY1, ADCY7, RAB11A | More | | Nifedipine | hsa04975 | Fat digestion and absorption | 9.50E-04 | 1 | O14494 | PLPP1 | More | | Nifedipine | hsa04976 | Bile secretion | 1.51E-03 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | | Nifedipine | hsa05010 | Alzheimer disease | 7.11E-03 | 9 | O15239, P13073, P18848, O15169, P67870, P05141, P12236, P28070, P43686 | NDUFA1, COX4I1, ATF4, AXIN1, CSNK2B, SLC25A5, SLC25A6, PSMB4, PSMC4 | More | | Nifedipine | hsa05012 | Parkinson disease | 2.14E-02 | 7 | O15239, P13073, P05141, P12236, P18848, P28070, P43686 | NDUFA1, COX4I1, SLC25A5, SLC25A6, ATF4, PSMB4, PSMC4 | More | | Nifedipine | hsa05014 | Amyotrophic lateral sclerosis | 2.98E-02 | 3 | P36542, P60709, P63261 | ATP5C1, ACTB, ACTG1 | More | | Nifedipine | hsa05016 | Huntington disease | 2.46E-05 | 3 | Q9GZM3, P52435, Q9NYC9 | POLR2J2, POLR2J, DNAH9 | More | | Nifedipine | hsa05017 | Spinocerebellar ataxia | 4.93E-04 | 10 | P17252, O75460, Q8TB72, O15399, P31751, P28070, P43686, O00232, P05141, P12236 | PRKCA, ERN1, PUM2, GRIN2D, AKT2, PSMB4, PSMC4, PSMD12, SLC25A5, SLC25A6 | More | | Nifedipine | hsa05020 | Prion disease | 1.55E-03 | 10 | P46531, O15239, P13073, P18848, P05141, P12236, P28070, P43686, P67870, P51636 | NOTCH1, NDUFA1, COX4I1, ATF4, SLC25A5, SLC25A6, PSMB4, PSMC4, CSNK2B, CAV2 | More | | Nifedipine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 5.20E-04 | 15 | P67870, O15239, Q16718, P13073, P18848, Q13561, P48058, P05141, P12236, P17252, P20333, O15169, Q08752, P28070, P43686 | CSNK2B, NDUFA1, NDUFA5, COX4I1, ATF4, DCTN2, GRIA4, SLC25A5, SLC25A6, PRKCA, TNFRSF1B, AXIN1, PPID, PSMB4, PSMC4 | More | | Nifedipine | hsa05031 | Amphetamine addiction | 2.07E-03 | 7 | O15399, P48058, P0DP23, Q13557, P22694, P18848, P17252 | GRIN2D, GRIA4, CALM1, CAMK2D, PRKACB, ATF4, PRKCA | More | | Nifedipine | hsa05032 | Morphine addiction | 4.08E-02 | 5 | Q08828, P51828, P62873, Q13370, P17252 | ADCY1, ADCY7, GNB1, PDE3B, PRKCA | More | | Nifedipine | hsa05100 | Bacterial invasion of epithelial cells | 8.79E-04 | 3 | P60709, P63261, Q92529 | ACTB, ACTG1, SHC3 | More | | Nifedipine | hsa05110 | Vibrio cholerae infection | 4.61E-04 | 4 | P17252, P22694, P60709, P63261 | PRKCA, PRKACB, ACTB, ACTG1 | More | | Nifedipine | hsa05131 | Shigellosis | 1.91E-02 | 3 | P60709, P63261, P07384 | ACTB, ACTG1, CAPN1 | More | | Nifedipine | hsa05132 | Salmonella infection | 1.85E-06 | 17 | P51617, P01584, P25963, P08238, Q96RF0, Q13546, Q13489, P10415, P08575, O75369, Q9BQS8, Q13561, O60282, Q13509, P68371, P49754, Q9NP90 | IRAK1, IL1B, NFKBIA, HSP90AB1, SNAG1, RIPK1, BIRC3, BCL2, PTPRC, FLNB, FYCO1, DCTN2, KIF5C, TUBB3, TUBB2C, VPS41, RAB9B | More | | Nifedipine | hsa05133 | Pertussis | 3.94E-04 | 5 | P0DP23, P01584, P23528, P09871, P51617 | CALM1, IL1B, CFL1, C1S, IRAK1 | More | | Nifedipine | hsa05135 | Yersinia infection | 3.88E-03 | 3 | P60709, P63261, Q16513 | ACTB, ACTG1, PKN2 | More | | Nifedipine | hsa05140 | Leishmaniasis | 2.58E-02 | 5 | P14598, O60603, P25963, P29350, Q15080 | NCF1, TLR2, NFKBIA, PTPN6, NCF4 | More | | Nifedipine | hsa05143 | African trypanosomiasis | 3.87E-02 | 3 | P01584, P17252, P01042 | IL1B, PRKCA, KNG1 | More | | Nifedipine | hsa05145 | Toxoplasmosis | 7.31E-06 | 10 | P51617, P25963, P10415, Q13489, P23458, P42224, P31751, P11142, P29965, Q13651 | IRAK1, NFKBIA, BCL2, BIRC3, JAK1, STAT1, AKT2, HSPA8, CD40LG, IL10RA | More | | Nifedipine | hsa05150 | Staphylococcus aureus infection | 4.36E-02 | 2 | P0C0L4, P13646 | C4A, KRT13 | More | | Nifedipine | hsa05161 | Hepatitis B | 1.11E-05 | 12 | P17252, P18848, P23458, P25963, Q13485, P31751, P10415, P27348, P84022, P01568, P42224, P51617 | PRKCA, ATF4, JAK1, NFKBIA, SMAD4, AKT2, BCL2, YWHAQ, SMAD3, IFNA21, STAT1, IRAK1 | More | | Nifedipine | hsa05162 | Measles | 1.74E-04 | 10 | P51617, P01568, P23458, P42224, P14784, P31751, P11142, P01584, Q9NP90, P10415 | IRAK1, IFNA21, JAK1, STAT1, IL2RB, AKT2, HSPA8, IL1B, RAB9B, BCL2 | More | | Nifedipine | hsa05163 | Human cytomegalovirus infection | 2.59E-03 | 14 | P31751, P62873, P0DP23, Q8NHW4, Q08828, P51828, P23458, P01584, P61073, P17252, Q13651, P18848, P61769, P01568 | AKT2, GNB1, CALM1, CCL4L2, ADCY1, ADCY7, JAK1, IL1B, CXCR4, PRKCA, IL10RA, ATF4, B2M, IFNA21 | More | | Nifedipine | hsa05164 | Influenza A | 7.10E-03 | 3 | P48551, P60709, P63261 | IFNAR2, ACTB, ACTG1 | More | | Nifedipine | hsa05168 | Herpes simplex virus 1 infection | 2.45E-05 | 18 | P01568, P01584, Q9UBU9, P23458, P42224, Q07955, Q01130, Q13243, Q13489, P51617, P61769, P31751, Q13398, Q6P280, Q03923, Q9UDV6, P10415, Q14232 | IFNA21, IL1B, NXF1, JAK1, STAT1, SFRS1, SFRS2, SFRS5, BIRC3, IRAK1, B2M, AKT2, ZNF211, ZNF529, ZNF85, ZNF212, BCL2, EIF2B1 | More | | Nifedipine | hsa05170 | Human immunodeficiency virus 1 infection | 4.12E-05 | 12 | P31751, P62873, P0DP23, P61073, P17252, P61769, P01568, P51617, P19174, P23528, P10415, Q9Y6Q5 | AKT2, GNB1, CALM1, CXCR4, PRKCA, B2M, IFNA21, IRAK1, PLCG1, CFL1, BCL2, AP1M2 | More | | Nifedipine | hsa05171 | Coronavirus disease - COVID-19 | 1.08E-04 | 13 | P23396, P62753, P62249, P42677, P40429, P36578, Q02878, P62917, P32969, Q07020, P46776, P62910, P05386 | RPS3, RPS6, RPS16, RPS27, RPL13A, RPL4, RPL6, RPL8, RPL9, RPL18, RPL27A, RPL32, RPLP1 | More | | Nifedipine | hsa05200 | Pathways in cancer | 4.30E-09 | 28 | P23458, P08238, P42224, P19174, Q15311, P17252, P43246, Q13485, P14923, P10415, Q13489, P49767, P31751, Q08828, P51828, P62873, P61073, P78417, O75293, Q15788, P0DP23, Q13557, O43521, P01568, P14784, P16871, P00734, P01042 | JAK1, HSP90AB1, STAT1, PLCG1, RALBP1, PRKCA, MSH2, SMAD4, JUP, BCL2, BIRC3, VEGFC, AKT2, ADCY1, ADCY7, GNB1, CXCR4, GSTO1, GADD45B, NCOA1, CALM1, CAMK2D, BCL2L11, IFNA21, IL2RB, IL7R, F2, KNG1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P0DP23 | CALM1 | Calmodulin-1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.822 | P0DP24 | CALM2 | Calmodulin-2 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.738 | P0DP23 | CALM1 | Calmodulin-1 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P0DP25 | CALM3 | Calmodulin-3 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P0DP24 | CALM2 | Calmodulin-2 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P0DP23 | CALM1 | Calmodulin-1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P0DP25 | CALM3 | Calmodulin-3 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P0DP24 | CALM2 | Calmodulin-2 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P0DP23 | CALM1 | Calmodulin-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP25 | CALM3 | Calmodulin-3 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP24 | CALM2 | Calmodulin-2 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP23 | CALM1 | Calmodulin-1 | Q15311 | RALBP1 | RalA-binding protein 1 | 0.858 | P0DP23 | CALM1 | Calmodulin-1 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P0DP25 | CALM3 | Calmodulin-3 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P0DP24 | CALM2 | Calmodulin-2 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P0DP23 | CALM1 | Calmodulin-1 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.944 | P0DP25 | CALM3 | Calmodulin-3 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.944 | P0DP24 | CALM2 | Calmodulin-2 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.944 | P0DP23 | CALM1 | Calmodulin-1 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.777 | P0DP25 | CALM3 | Calmodulin-3 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.777 | P0DP24 | CALM2 | Calmodulin-2 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.777 | P0DP23 | CALM1 | Calmodulin-1 | P14923 | JUP | Junction plakoglobin | -0.852 | P0DP25 | CALM3 | Calmodulin-3 | P14923 | JUP | Junction plakoglobin | -0.852 | P0DP24 | CALM2 | Calmodulin-2 | P14923 | JUP | Junction plakoglobin | -0.852 | P0DP23 | CALM1 | Calmodulin-1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP25 | CALM3 | Calmodulin-3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP24 | CALM2 | Calmodulin-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP23 | CALM1 | Calmodulin-1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP25 | CALM3 | Calmodulin-3 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP24 | CALM2 | Calmodulin-2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP23 | CALM1 | Calmodulin-1 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | P0DP25 | CALM3 | Calmodulin-3 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | P0DP24 | CALM2 | Calmodulin-2 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | P0DP23 | CALM1 | Calmodulin-1 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.761 | P0DP23 | CALM1 | Calmodulin-1 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.725 | P0DP24 | CALM2 | Calmodulin-2 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.711 | P0DP23 | CALM1 | Calmodulin-1 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.719 | P0DP23 | CALM1 | Calmodulin-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P0DP25 | CALM3 | Calmodulin-3 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P0DP24 | CALM2 | Calmodulin-2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P0DP24 | CALM2 | Calmodulin-2 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | 0.759 | P0DP23 | CALM1 | Calmodulin-1 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.804 | P0DP25 | CALM3 | Calmodulin-3 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.804 | P0DP24 | CALM2 | Calmodulin-2 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.804 | P0DP23 | CALM1 | Calmodulin-1 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP25 | CALM3 | Calmodulin-3 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP24 | CALM2 | Calmodulin-2 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP24 | CALM2 | Calmodulin-2 | Q15788 | NCOA1 | Nuclear receptor coactivator 1 | 0.731 | P0DP23 | CALM1 | Calmodulin-1 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP25 | CALM3 | Calmodulin-3 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP24 | CALM2 | Calmodulin-2 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP24 | CALM2 | Calmodulin-2 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.786 | P0DP24 | CALM2 | Calmodulin-2 | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.75 | P0DP23 | CALM1 | Calmodulin-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP25 | CALM3 | Calmodulin-3 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP24 | CALM2 | Calmodulin-2 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP23 | CALM1 | Calmodulin-1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | P0DP25 | CALM3 | Calmodulin-3 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | P0DP24 | CALM2 | Calmodulin-2 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | P0DP23 | CALM1 | Calmodulin-1 | P16871 | IL7R | Interleukin-7 receptor subunit alpha | 0.718 | P0DP23 | CALM1 | Calmodulin-1 | P00734 | F2 | Prothrombin | -0.738 | P0DP23 | CALM1 | Calmodulin-1 | P01042 | KNG1 | Kininogen-1 | -0.71 | P0DP25 | CALM3 | Calmodulin-3 | P01042 | KNG1 | Kininogen-1 | -0.71 | P0DP24 | CALM2 | Calmodulin-2 | P01042 | KNG1 | Kininogen-1 | -0.71 |
| Nifedipine | hsa05204 | Chemical carcinogenesis | 3.70E-03 | 3 | P00325, P78417, P33260 | ADH1B, GSTO1, CYP2C18 | More | | Nifedipine | hsa05206 | MicroRNAs in cancer | 4.07E-02 | 2 | P15311, P63279 | VIL2, UBE2I | More | | Nifedipine | hsa05210 | Colorectal cancer | 1.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Nifedipine | hsa05212 | Pancreatic cancer | 5.79E-04 | 7 | P31751, Q15311, P23458, P42224, P84022, Q13485, O75293 | AKT2, RALBP1, JAK1, STAT1, SMAD3, SMAD4, GADD45B | More | | Nifedipine | hsa05214 | Glioma | 2.38E-06 | 8 | P09619, P0DP23, Q13557, P17252, Q02750, P31751, P19174, O75293 | PDGFRB, CALM1, CAMK2D, PRKCA, MAP2K1, AKT2, PLCG1, GADD45B | More | | Nifedipine | hsa05218 | Melanoma | 1.34E-02 | 2 | P09619, Q02750 | PDGFRB, MAP2K1 | More | | Nifedipine | hsa05220 | Chronic myeloid leukemia | 1.25E-02 | 3 | Q13485, P25963, P84022 | SMAD4, NFKBIA, SMAD3 | More | | Nifedipine | hsa05222 | Small cell lung cancer | 1.50E-02 | 3 | Q13489, P10415, P25963 | BIRC3, BCL2, NFKBIA | More | | Nifedipine | hsa05224 | Breast cancer | 3.88E-02 | 3 | P46531, Q9UM47, O15169 | NOTCH1, NOTCH3, AXIN1 | More | | Nifedipine | hsa05225 | Hepatocellular carcinoma | 4.07E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Nifedipine | hsa05226 | Gastric cancer | 2.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Nifedipine | hsa05230 | Central carbon metabolism in cancer | 4.10E-02 | 2 | P09619, Q02750 | PDGFRB, MAP2K1 | More | | Nifedipine | hsa05340 | Primary immunodeficiency | 2.68E-02 | 2 | P11912, P07766 | CD79A, CD3E | More | | Nifedipine | hsa05410 | Hypertrophic cardiomyopathy | 1.02E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Nifedipine | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 8.96E-03 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Nifedipine | hsa05414 | Dilated cardiomyopathy | 1.73E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Nifedipine | hsa05415 | Diabetic cardiomyopathy | 2.75E-02 | 4 | P17252, P14598, Q15080, Q16718 | PRKCA, NCF1, NCF4, NDUFA5 | More | | Nifedipine | hsa05416 | Viral myocarditis | 8.96E-03 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Nifedipine | hsa05418 | Fluid shear stress and atherosclerosis | 3.64E-03 | 8 | P14598, P78417, P60709, P63261, P10415, P0DP23, P08238, Q92974 | NCF1, GSTO1, ACTB, ACTG1, BCL2, CALM1, HSP90AB1, ARHGEF2 | More | | |